Financial Shenanigans
Financial Shenanigans
Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.
Schneider Electric is a serial acquirer with strong reported cash conversion, but the cash conversion is partly bought with a 50-day extension of payment terms to suppliers since 2019 and a non-GAAP framework that excludes $400M-plus of recurring intangible amortization and $350M of "restructuring" every year. There is no restatement, no auditor resignation, and no SEC inquiry; the most concrete external problem is a $243M French Competition Authority fine for resale-price-fixing conduct from 2012-2018 (announced October 2024, under appeal) plus a smaller 2020 US DOJ cost-inflation settlement at the Buildings Americas subsidiary. We grade this Watch (32/100): the income statement looks earned, but two structural items — supplier-financing tailwind to CFO and aggressive Adjusted EBITA framing — are large enough to matter at the margin. The single data point that would change the grade is a roll-back of DPO toward the 2019 ~93-day baseline; if that happens and FCF holds, the grade tightens to Clean.
The Forensic Verdict
Forensic Risk Score (0-100)
Red Flags
Yellow Flags
3y CFO / Net Income
3y FCF / Net Income
Accrual Ratio (FY25)
Receivables Growth − Revenue Growth (ppt, FY25)
Goodwill + Intangibles / Total Assets
Grade: Watch (32/100). Top concerns: (1) DPO extension from 93 days in FY2019 to 143 days in FY2025 has injected an estimated $3.5B-$4.1B of cumulative working-capital benefit into operating cash flow; (2) Adjusted EBITA excludes $420M+ of recurring intangible amortization, $350M of recurring "restructuring", and the $229M FY2024 associate impairment. Cleanest offset: no restatement, no auditor change, accrual ratio negative every year since FY2018, DSO stable.
Shenanigans scorecard — 13 categories
There are no red flags. The page below works through what we mean by yellow, and why none of these escalate.
Breeding Ground
The governance architecture is largely investor-friendly, but pay design and the long Tricoire era still anchor management with significant institutional memory. The breeding-ground risks are moderate, dampening rather than amplifying the accounting signals.
The pay-metric mix is the most relevant breeding-ground signal: 75% of LTI is financial, weighted toward Adjusted EBITA margin and FCF conversion. Both are precisely the metrics where Schneider exercises the most accounting framing — Adjusted EBITA excludes $420M+ of recurring intangible amortization and "restructuring" that has appeared every year since at least FY2018, and FCF conversion benefits from the supplier-financing tailwind discussed in section 4. The committee chairs are credentialed (Jill Lee on audit; Knoll on remuneration), and pay ratios (50-115x across French and global perimeter) are mid-pack for European industrials. None of this is unusual for a CAC-40 industrial, but it means the headline metrics management chooses are also the metrics they are paid on — a structural reason to read those metrics with extra scrutiny rather than at face value.
Earnings Quality
The income statement passes the most important tests — revenue is not running ahead of receivables, operating margins are growing through organic mix shift toward software and services, and provisions are tracking growth. The yellow flags are concentrated in the lump of one-off charges in FY2024-25 and the related intangibles intensity from acquisitions.
Trade receivables have grown 60% over the FY2018-FY2025 period, broadly matching revenue's 60% growth. DSO ranges from 99 to 114 days with no breakout. Whatever pressure exists on Schneider's working capital is on the payables side, not the receivables side.
Restructuring has been incurred every year since 2018 — $147-353M annually. Purchase-accounting amortization has been $420-545M annually since the Invensys-era deals. The $229M FY2024 impairment of investments in associates is the first such charge in the modern Schneider era and signals stress in one or more equity-method investees (StarCharge, Planon, Industrial Defender, or AESL are the candidates given recent disclosure). A second associate impairment appeared in FY2025 alongside the cash payment of the French fine. We treat the concentration of FY24-25 charges as a yellow flag for big-bath behavior around the Herweck-to-Blum CEO transition, but the items are individually plausible and the bath is small relative to net income ($4.4B in FY24).
Capex runs persistently below D&A (0.4-0.65x). That is not abnormal for an asset-light electrical-equipment business where ~$420M of annual D&A reflects amortization of acquired customer relationships and trademarks — non-cash, non-replaceable items. Stripping out purchase-accounting amortization, the underlying capex/D&A is closer to 0.85-0.95x, which is healthy. The trajectory is the right way: capex is rising into the AI/data-center capex cycle ($1.26B FY25 vs $595M FY20).
Cash Flow Quality
Operating cash flow is consistently above reported earnings, but the reason matters: a large portion of the lift since FY2019 comes from stretching suppliers, not from underlying earning power.
Three-year (FY23-25) CFO / NI = 1.36 and FCF / NI = 1.13; five-year averages are 1.29 and 1.08. The 1.13x FCF/NI is solid but not extraordinary for a high-quality industrial. The headline 111% cash conversion claim in the FY2025 earnings release rests on a narrower definition (FCF / Net Income Group Share, excluding minorities) and management's own commentary notes the 111% was boosted by the non-cash associate impairment plus payment of the French fine; on an "equivalent basis" they cite 106% — still healthy but 5 points lower than the headline.
The yellow flag in plain sight. Days payable outstanding rose from 93 days at year-end FY2019 to 143 days at year-end FY2025 — a 50-day extension to suppliers. Multiplying the change by FY2025 cost of goods sold ($27.3B) implies roughly $3.5-$4.1B of cumulative cash benefit from supplier stretch over six years. The cash conversion cycle compressed from 78 days to 49 days entirely on the back of DPO, with DSO essentially flat and DIO drifting up. This is a real working-capital improvement (vendor-favored terms are a procurement win), but it is also a one-time, capped tailwind to reported CFO. If DPO normalizes by even 20 days, CFO could give back $1.2-$1.5B annually. Recent IFRS adoption of IAS 7 / IFRS 7 supplier-finance disclosures (FY2024) is welcome, but Schneider has not disclosed the supplier-finance program magnitude or % of payables financed.
After-acquisition FCF is the harder, more honest cash-flow number. In FY2021, after-acquisition FCF was negative $1.31B as Schneider closed the AVEVA majority-purchase-related funding. FY2023 enjoyed a +$675M boost from net divestiture activity (mainly the consolidation of AVEVA's non-controlling-interest buyout structure plus minor disposals), which flattered headline FCF/NI by an estimated 15 points that year. Stripping that out, FY2023 underlying FCF/NI is closer to 1.05x. We do not see this as accounting manipulation — Schneider discloses acquisitions and disposals separately — but management's preferred "cash conversion" number rolls up the noise into a single, flattering metric.
Metric Hygiene
Schneider's chosen scoreboard is Adjusted EBITA, Adjusted EBITA margin, organic revenue growth, and cash conversion. Each is sound on its own and audited within the URD reconciliations, but the gap to GAAP earnings has widened, and the FY2025 cash-conversion headline is the most aggressive presentation we found.
The gap between Adjusted EBITA margin and GAAP operating margin has been stable at 130-320 bp, widening modestly in FY2025. This is consistent with steady purchase-accounting amortization plus the FY24-25 lump of charges. The gap is not pathological — Schneider discloses the bridge each year — but the LTI plan ties a meaningful portion of pay to the Adjusted figure, so the gap is the lens through which to read pay-for-performance.
What to Underwrite Next
This is a credible compounder with an honest income statement; the diligence list is short and specific.
Bottom line for underwriting. Forensic risk at Schneider Electric does not change the investment thesis on direction, but it should compress the valuation premium by a few turns versus a clean compounder. We would not pay the full peer multiple for Adjusted EBITA without discounting it by 5-8% to reflect the recurring nature of "non-recurring" exclusions, and we would model FY2026-27 FCF assuming DPO holds rather than extends further. The accounting risk here is a small-but-real valuation haircut, not a position-sizing limiter and certainly not a thesis breaker. The $243M French fine and the FY24-25 lump of impairments and other operating items are the most visible signs of stress, and they are disclosed, accrued, and being paid through; they do not signal hidden problems.